Doğrulama için verilen süre doldu. Lütfen yenileyin.

Şifremi Unuttum

ECDC’den 2019 Ocak Ayında 10 Yeni Yayın

Corporate publication
 

 

Single programming document 2019–2021
Date of publication: 11 January 20192019 will be a year of transformation for Europe. Despite these changes, ECDC will further demonstrate its efficiency and usefulness by providing added value in the area of European public health. The Single Programming Document constitutes an essential element for the guidance of ECDC’s work and its resource allocation.Available from the ECDC website

Mission report
 

 

ECDC country visit to Norway to discuss antimicrobial resistance issues
Date of publication: 16 January 2019An ECDC country visit team conducted an assessment mission during the period 12–16 March 2018 to discuss antimicrobial resistance (AMR) issues in Norway. The overall objective of the mission was to provide an observation-based assessment of the situation in Norway regarding prevention and control of AMR through prudent use of antibiotics and infection control.Available from the ECDC website

Technical reports
 

 

HIV Estimates Accuracy Tool manual
Date of publication: 31 January 2019The HIV Estimates Accuracy Tool is an R-based application that uses statistical methods to allow for adjusted estimates from HIV surveillance data taking into account the issues of missing data and reporting delay. While it does not replace the knowledge of data analysis with adjustments, it is intended for routine application in surveillance as no complex programming skills are needed.Available from the ECDC website

 

 

Expert consensus protocol on colistin resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
Date of publication: 14 January 2019This expert consensus protocol for colistin resistance detection and characterisation was jointly developed by the EURGenCCRE consortium, the scientific advisory board for EURGen-Net and ECDC to agree upon the best available strategy for phenotypic and genotypic colistin-resistance detection and confirmation to be used for the CCRE survey. A separate expert consensus protocol was also developed for carbapenem resistance detection and characterisation, as well as a laboratory manual with detailed methodological information for characterisation of CCRE isolates.Available from the ECDC website

 

 

Expert consensus protocol on carbapenem resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
Date of publication: 14 January 2019This expert consensus protocol for carbapenem resistance detection and characterisation was jointly developed by the EURGenCCRE consortium, the scientific advisory board for EURGen-Net and ECDC to agree upon the protocol for phenotypic and genotypic carbapenem resistance detection and confirmation to be used for the CCRE survey. The primary objective of the CCRE survey is to determine the occurrence, geographic distribution and population dynamics within the healthcare setting of high-risk CCRE clones and/or transmissible resistance/genetic elements of critical public health importance in Europe in order to enable informed risk assessment and control policies.Available from the ECDC website

 

 

External quality assessment for the detection of Bordetella pertussis by PCR, 2018
Date of publication: 11 January 2019Laboratory confirmation of pertussis is integral to surveillance, especially to monitor the effectiveness of vaccination strategies and inform any changes to national policies. This report presents the results of the second European Pertussis Laboratory Surveillance Network (EUPert-LabNet) EQA scheme for Bordetella pertussis PCR funded by ECDC on behalf of EUPert-LabNet. The EQA study was conducted between February and March 2018.Available from the ECDC website

 

 

Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – ECDC PPS validation protocol version 3.1.2.
Date of publication: 10 January 2019The current protocol version 3.2.1 is the ECDC PPS validation protocol used during the second EU-wide PPS of HAIs and antimicrobial use in 2016–2017. This protocol version is an accompanying document to the ECDC protocol for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals version 5.3.Available from the ECDC website

Surveillance reports
 

 

Influenza virus characterisation, Summary Europe, December 2018
Date of publication: 21 January 2019The ECDC Influenza Virus Characterisations Reports are published periodically. The report provides an overview of the technical details of the circulating influenza viruses, such as antigenic and genetic properties, with a reference to the current vaccine strains. It also summaries the developments of the viruses since the last report, as well as the main developments for the ongoing season. The report is of special interest for influenza virologists and epidemiologists interested in the in-depth characterisation of influenza viruses.Available from the ECDC website

 

 

Monthly measles and rubella monitoring report, November 2019
Date of publication: 11 January 2019ECDC reports monthly on measles and rubella surveillance data submitted by 30 EU/EEA countries to the European Surveillance System (TESSy). This report is based on surveillance data reported to TESSy. ECDC also monitors European measles outbreaks through epidemic intelligence and publishes the most recent updates monthly in the Communicable Disease Threats Report (CDTR).Available from the ECDC website

 

 

Annual Epidemiological Report series on communicable diseases in Europe
Date of publication: released as new disease chapters become availableThe Annual Epidemiological Report series on communicable diseases in Europe provides a comprehensive summary of surveillance data for EU/EEA countries. It is mainly intended for public health professionals and policymakers involved in infectious disease prevention and control.The overview of all disease chapters for 2014 and onwards is available on the ECDC websitePublished in January:
Chapter on zoonotic influenza for 2017 on the ECDC website
Chapter on hepatitis A for 2016 on the ECDC website
Chapter on Legionnaires’ disease for 2017 on the ECDC website
Chapter on cholera for 2017 on the ECDC website
Chapter on tularaemia for 2016 on the ECDC website
Chapter on congenital syphilis for 2017 on the ECDC website
Chapter on Q fever for 2016 on the ECDC website
Chapter on chlamydia infection for 2017 on the ECDC website

 

 

ECDC communicable disease threats report
Date of publication: every FridayThe ECDC communicable disease threats report is a weekly bulletin intended for epidemiologists and health professionals in the area of communicable disease prevention and control. Summarising information gathered by ECDC through its epidemic intelligence activities regarding communicable disease threats of concern to the European Union, it also provides updates on the global situation and changes in the epidemiology of communicable diseases with potential to affect Europe, including diseases that are the focus of eradication efforts.Available from the ECDC website

Scientific peer-reviewed publications
 

 

Publications by ECDC staff in scientific journals

All scientific peer-reviewed publications produced by ECDC staff on behalf of the Centre for the period January 2005 – June 2018 are available online.Available from the ECDC website